Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 Pathway.
Identifieur interne : 000101 ( Main/Exploration ); précédent : 000100; suivant : 000102Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 Pathway.
Auteurs : Mohammedyaseen Syedbasha [Suisse] ; Ferdinando Bonfiglio [Suisse] ; Janina Linnik [Suisse] ; Claudia Stuehler [Suisse] ; Daniel Wüthrich [Suisse] ; Adrian Egli [Suisse]Source :
- Cell reports [ 2211-1247 ] ; 2020.
Abstract
Type III interferon (interferon lambda [IFN-λ]) is known to be a potential immune modulator, but the mechanisms behind its immune-modulatory functions and its impact on plasmablast differentiation in humans remain unknown. Human B cells and their subtypes directly respond to IFN-λ. Using B cell transcriptome profiling, we investigate the immune-modulatory role of IFN-λ in B cells. We find that IFN-λ-induced gene expression in B cells is steady, prolonged, and importantly, cell type specific. Furthermore, IFN-λ enhances the mTORC1 (mammalian/mechanistic target of rapamycin complex 1) pathway in B cells activated by the B cell receptor (BCR/anti-IgM). Engagement of mTORC1 by BCR and IFN-λ induces cell-cycle progress in B cells. Subsequently, IFN-λ boosts the differentiation of naive B cells into plasmablasts upon activation, and the cells gain effector functions such as cytokine release (IL-6 and IL-10) and antibody production. Our study shows how IFN-λ systematically boosts the differentiation of naive B cells into plasmablasts by enhancing the mTORC1 pathway and cell-cycle progression in activated B cells.
DOI: 10.1016/j.celrep.2020.108211
PubMed: 33027651
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 Pathway.</title>
<author><name sortKey="Syedbasha, Mohammedyaseen" sort="Syedbasha, Mohammedyaseen" uniqKey="Syedbasha M" first="Mohammedyaseen" last="Syedbasha">Mohammedyaseen Syedbasha</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland. Electronic address: m.syedbasha@unibas.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonfiglio, Ferdinando" sort="Bonfiglio, Ferdinando" uniqKey="Bonfiglio F" first="Ferdinando" last="Bonfiglio">Ferdinando Bonfiglio</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Linnik, Janina" sort="Linnik, Janina" uniqKey="Linnik J" first="Janina" last="Linnik">Janina Linnik</name>
<affiliation wicri:level="1"><nlm:affiliation>Swiss Institute for Bioinformatics, Basel, Switzerland; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Swiss Institute for Bioinformatics, Basel, Switzerland; Department of Biosystems Science and Engineering, ETH Zurich, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stuehler, Claudia" sort="Stuehler, Claudia" uniqKey="Stuehler C" first="Claudia" last="Stuehler">Claudia Stuehler</name>
<affiliation wicri:level="1"><nlm:affiliation>Infection Biology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Infection Biology Laboratory, Department of Biomedicine, University of Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wuthrich, Daniel" sort="Wuthrich, Daniel" uniqKey="Wuthrich D" first="Daniel" last="Wüthrich">Daniel Wüthrich</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Egli, Adrian" sort="Egli, Adrian" uniqKey="Egli A" first="Adrian" last="Egli">Adrian Egli</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland. Electronic address: adrian.egli@usb.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33027651</idno>
<idno type="pmid">33027651</idno>
<idno type="doi">10.1016/j.celrep.2020.108211</idno>
<idno type="wicri:Area/Main/Corpus">000016</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000016</idno>
<idno type="wicri:Area/Main/Curation">000016</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000016</idno>
<idno type="wicri:Area/Main/Exploration">000016</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 Pathway.</title>
<author><name sortKey="Syedbasha, Mohammedyaseen" sort="Syedbasha, Mohammedyaseen" uniqKey="Syedbasha M" first="Mohammedyaseen" last="Syedbasha">Mohammedyaseen Syedbasha</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland. Electronic address: m.syedbasha@unibas.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonfiglio, Ferdinando" sort="Bonfiglio, Ferdinando" uniqKey="Bonfiglio F" first="Ferdinando" last="Bonfiglio">Ferdinando Bonfiglio</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Linnik, Janina" sort="Linnik, Janina" uniqKey="Linnik J" first="Janina" last="Linnik">Janina Linnik</name>
<affiliation wicri:level="1"><nlm:affiliation>Swiss Institute for Bioinformatics, Basel, Switzerland; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Swiss Institute for Bioinformatics, Basel, Switzerland; Department of Biosystems Science and Engineering, ETH Zurich, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stuehler, Claudia" sort="Stuehler, Claudia" uniqKey="Stuehler C" first="Claudia" last="Stuehler">Claudia Stuehler</name>
<affiliation wicri:level="1"><nlm:affiliation>Infection Biology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Infection Biology Laboratory, Department of Biomedicine, University of Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wuthrich, Daniel" sort="Wuthrich, Daniel" uniqKey="Wuthrich D" first="Daniel" last="Wüthrich">Daniel Wüthrich</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Egli, Adrian" sort="Egli, Adrian" uniqKey="Egli A" first="Adrian" last="Egli">Adrian Egli</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland. Electronic address: adrian.egli@usb.ch.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Cell reports</title>
<idno type="eISSN">2211-1247</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Type III interferon (interferon lambda [IFN-λ]) is known to be a potential immune modulator, but the mechanisms behind its immune-modulatory functions and its impact on plasmablast differentiation in humans remain unknown. Human B cells and their subtypes directly respond to IFN-λ. Using B cell transcriptome profiling, we investigate the immune-modulatory role of IFN-λ in B cells. We find that IFN-λ-induced gene expression in B cells is steady, prolonged, and importantly, cell type specific. Furthermore, IFN-λ enhances the mTORC1 (mammalian/mechanistic target of rapamycin complex 1) pathway in B cells activated by the B cell receptor (BCR/anti-IgM). Engagement of mTORC1 by BCR and IFN-λ induces cell-cycle progress in B cells. Subsequently, IFN-λ boosts the differentiation of naive B cells into plasmablasts upon activation, and the cells gain effector functions such as cytokine release (IL-6 and IL-10) and antibody production. Our study shows how IFN-λ systematically boosts the differentiation of naive B cells into plasmablasts by enhancing the mTORC1 pathway and cell-cycle progression in activated B cells.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">33027651</PMID>
<DateRevised><Year>2020</Year>
<Month>10</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>33</Volume>
<Issue>1</Issue>
<PubDate><Year>2020</Year>
<Month>Oct</Month>
<Day>06</Day>
</PubDate>
</JournalIssue>
<Title>Cell reports</Title>
<ISOAbbreviation>Cell Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 Pathway.</ArticleTitle>
<Pagination><MedlinePgn>108211</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S2211-1247(20)31200-6</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2020.108211</ELocationID>
<Abstract><AbstractText>Type III interferon (interferon lambda [IFN-λ]) is known to be a potential immune modulator, but the mechanisms behind its immune-modulatory functions and its impact on plasmablast differentiation in humans remain unknown. Human B cells and their subtypes directly respond to IFN-λ. Using B cell transcriptome profiling, we investigate the immune-modulatory role of IFN-λ in B cells. We find that IFN-λ-induced gene expression in B cells is steady, prolonged, and importantly, cell type specific. Furthermore, IFN-λ enhances the mTORC1 (mammalian/mechanistic target of rapamycin complex 1) pathway in B cells activated by the B cell receptor (BCR/anti-IgM). Engagement of mTORC1 by BCR and IFN-λ induces cell-cycle progress in B cells. Subsequently, IFN-λ boosts the differentiation of naive B cells into plasmablasts upon activation, and the cells gain effector functions such as cytokine release (IL-6 and IL-10) and antibody production. Our study shows how IFN-λ systematically boosts the differentiation of naive B cells into plasmablasts by enhancing the mTORC1 pathway and cell-cycle progression in activated B cells.</AbstractText>
<CopyrightInformation>Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Syedbasha</LastName>
<ForeName>Mohammedyaseen</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland. Electronic address: m.syedbasha@unibas.ch.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bonfiglio</LastName>
<ForeName>Ferdinando</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Linnik</LastName>
<ForeName>Janina</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Swiss Institute for Bioinformatics, Basel, Switzerland; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stuehler</LastName>
<ForeName>Claudia</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Infection Biology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wüthrich</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Swiss Institute for Bioinformatics, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Egli</LastName>
<ForeName>Adrian</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland; Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland. Electronic address: adrian.egli@usb.ch.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Cell Rep</MedlineTA>
<NlmUniqueID>101573691</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cell activation</Keyword>
<Keyword MajorTopicYN="N">JAK-STAT signaling</Keyword>
<Keyword MajorTopicYN="N">cell cycle</Keyword>
<Keyword MajorTopicYN="N">effector function</Keyword>
<Keyword MajorTopicYN="N">immune modulation</Keyword>
<Keyword MajorTopicYN="N">interferon lambda</Keyword>
<Keyword MajorTopicYN="N">mTORC1 pathway</Keyword>
<Keyword MajorTopicYN="N">phosphorylation</Keyword>
<Keyword MajorTopicYN="N">plasmablast differentiation</Keyword>
<Keyword MajorTopicYN="N">transcriptomics</Keyword>
</KeywordList>
<CoiStatement>Declaration of Interests The authors declare no competing interests.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year>
<Month>10</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>06</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>09</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>7</Day>
<Hour>20</Hour>
<Minute>5</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>10</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33027651</ArticleId>
<ArticleId IdType="pii">S2211-1247(20)31200-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.celrep.2020.108211</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Suisse</li>
</country>
</list>
<tree><country name="Suisse"><noRegion><name sortKey="Syedbasha, Mohammedyaseen" sort="Syedbasha, Mohammedyaseen" uniqKey="Syedbasha M" first="Mohammedyaseen" last="Syedbasha">Mohammedyaseen Syedbasha</name>
</noRegion>
<name sortKey="Bonfiglio, Ferdinando" sort="Bonfiglio, Ferdinando" uniqKey="Bonfiglio F" first="Ferdinando" last="Bonfiglio">Ferdinando Bonfiglio</name>
<name sortKey="Egli, Adrian" sort="Egli, Adrian" uniqKey="Egli A" first="Adrian" last="Egli">Adrian Egli</name>
<name sortKey="Linnik, Janina" sort="Linnik, Janina" uniqKey="Linnik J" first="Janina" last="Linnik">Janina Linnik</name>
<name sortKey="Stuehler, Claudia" sort="Stuehler, Claudia" uniqKey="Stuehler C" first="Claudia" last="Stuehler">Claudia Stuehler</name>
<name sortKey="Wuthrich, Daniel" sort="Wuthrich, Daniel" uniqKey="Wuthrich D" first="Daniel" last="Wüthrich">Daniel Wüthrich</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000101 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000101 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= RapamycinFungusV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:33027651 |texte= Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 Pathway. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33027651" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a RapamycinFungusV1
This area was generated with Dilib version V0.6.38. |